What are some of the issues for drug screening in 2024? And should we still test for marijuana?! These questions and more were answered during GroupOne Background Screening’s webinar “DRUG SCREENING 2024: Should we still test for marijuana? and other employer questions” originally broadcast on April 11. The event has now been posted online

This complimentary educational event included speakers John Gumina, vice president of development at i3screen; and David Graves, HR guru and sales rep at GroupOne. David asked John 11 questions about the latest drug screening issues for companies in the U.S.

You can view the webinar here.

For information, please contact Chris Wilson at chrisw@dfwhc.org.